Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

Ralph A. Defronzo; Andrew Lewin; Sanjay Patel; Dacheng Liu; Renee Kaste; Hans J. Woerle; Uli C. Broedl

doi:10.2337/dc15-er06

Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

Ralph A. Defronzo
, Andrew Lewin
, Sanjay Patel
, Dacheng Liu
, Renee Kaste
, Hans J. Woerle
, Uli C. Broedl

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1173
Number of pages	1
Journal	Diabetes Care
Volume	38
Issue number	6
DOIs	https://doi.org/10.2337/dc15-er06
State	Published - Jun 2015
Externally published	Yes

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/dc15-er06

Cite this

Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393)). / Defronzo, Ralph A.; Lewin, Andrew; Patel, Sanjay et al.
In: Diabetes Care, Vol. 38, No. 6, 06.2015, p. 1173.

Research output: Contribution to journal › Comment/debate › peer-review

@article{08d6ed8263e145e58a45f7a29acc9a63,

title = "Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))",

author = "Defronzo, \{Ralph A.\} and Andrew Lewin and Sanjay Patel and Dacheng Liu and Renee Kaste and Woerle, \{Hans J.\} and Broedl, \{Uli C.\}",

year = "2015",

month = jun,

doi = "10.2337/dc15-er06",

language = "English (US)",

volume = "38",

pages = "1173",

journal = "Diabetes Care",

issn = "0149-5992",

number = "6",

}

TY - JOUR

T1 - Erratum

T2 - Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

AU - Defronzo, Ralph A.

AU - Lewin, Andrew

AU - Patel, Sanjay

AU - Liu, Dacheng

AU - Kaste, Renee

AU - Woerle, Hans J.

AU - Broedl, Uli C.

PY - 2015/6

Y1 - 2015/6

UR - https://www.scopus.com/pages/publications/84962343788

UR - https://www.scopus.com/pages/publications/84962343788#tab=citedBy

U2 - 10.2337/dc15-er06

DO - 10.2337/dc15-er06

M3 - Comment/debate

C2 - 25998298

AN - SCOPUS:84962343788

SN - 0149-5992

VL - 38

SP - 1173

JO - Diabetes Care

JF - Diabetes Care

IS - 6

ER -

Erratum: Combination of empagliflozin and linagliptin as second-line therapy in subjects with type 2 diabetes inadequately controlled on metformin. (Diabetes care (2015) 38 (384-393))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this